/
PHRX
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2013 | |
|---|---|
| Revenue | $4.8K |
| Cost of revenue | $1.8K |
| Gross profit | $3.0K |
| Gross margin | 63.3% |
| R&D | $0 |
| Operating income | −$2.2K |
| EBITDA | −$2.9M |
| Net income | −$6.5K |
| Net margin | -134.2% |
| EPS (diluted) | -0.02 |
Annual figures · source: Financial Modeling Prep
Peer comparison
PHARMAGEN INC
PHARMAGEN INC
Held by traders on TradeandTell
No one on the platform currently holds PHRX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PHRX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PHRX yet.